 | • レポートコード：MRC2203A736 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料では、世界の羊膜市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、酵素別（凍結保存羊膜、乾燥羊膜）分析、用途別（眼科、外科的創傷、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来の傾向などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の羊膜市場規模：酵素別（凍結保存羊膜、乾燥羊膜） ・世界の羊膜市場規模：用途別（眼科、外科的創傷、その他） ・世界の羊膜市場規模：エンドユーザー別（病院、外来手術センター、その他） ・世界の羊膜市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Amnio Technology LLC、Celularity Inc.、Human Regenerative Technologies LLC、...） ・市場機会・将来の傾向 |
The amniotic membrane market is expected to register a CAGR of 10.5% during the forecast period. This can be attributed to the rise in the number of accident and trauma cases and increasing awareness about the benefits offered by the amniotic membrane.
Key Highlights
- Amniotic membrane has several antimicrobial and biological properties in corneal surgery, as it enhances epithelialization, reinforces adhesion of basal epithelial cells, maintains epithelial phenotype, and modulates the proliferation of normal corneal, conjunctival, and limbal fibroblast. These membranes also prevent apoptosis, as well as inhibit scarring, inflammation, and neovascularization.
- The advantages of amniotic membranes, like its pain-reducing properties, may lead to the rising adoption of these tissue-based products in ophthalmology and surgical wounds. Moreover, the growing number of surgeries performed and rising expenditure in R&D in the field of stem cells and regenerative medicine are also some of the key factors driving the overall market.
- As per the Global Burden of Diseases, in 2017, an estimate of 8,99,10,460.00 cases of burn injuries was registered globally. Driven by this high incidence of burn injuries, the inflammatory and anti-scarring properties of the amniotic membrane are pivotal in reducing intensified inflammation and discomfort and, thus, boost the overall market.
Key Market Trends
The Opthalmology Segment is Estimated to Witness a Healthy Growth in the Future.
The ophthalmology segment is estimated to witness a healthy growth in the future, which can be majorly attributed to the widespread use of these tissue-based products in ophthalmic surgeries due to their fast recovery properties, like reducing inflammation and promoting healing. The increasing use of the amniotic membrane in ophthalmic plastic and reconstructive surgeries to reduce scarring and diagnose quickly is propelling the segment growth. Moreover, the rising number of patients opting for surgeries, for the aesthetic appeal, is also boosting the amniotic membrane market. For instance, as per the American Society of Plastic Surgeons, in 2018, 17.7 million cosmetic procedures were carried out. The increasing demand for products in cosmetic surgeries and reconstructive surgeries is driving the overall market. Compared to xenografts and allografts, amniotic membranes are cheaper, which also promotes the segment growth.
In addition, the growing population of glaucoma patients globally fuels the amniotic membrane market, as these tissue-based products are used for the treatment for ocular surface diseases and in glaucoma for the repair of leaking glaucoma filtering blebs.
North America is Expected to Hold a Significant Share in the Market during the Forecast Period
North America is expected to hold a significant market share due to the increasing aging population, adoption of advanced technologies, growing awareness among the population about alternatives technologies, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure. The wide use of amniotic membranes is for eye surface disorders, leading to the adoption of these products in ophthalmic surgeries. Thus, the increasing number of ophthalmic surgeries performed in the United States, due to the geriatric population, is fueling the growth of the overall market to a large extent.
Competitive Landscape
The amniotic membrane market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies currently dominating the market include Amnio Technology LLC, Celularity Inc., Human Regenerative Technologies LLC, Katena Products Inc., MiMedx, Integra LifeSciences Corporation, Skye Biologics Inc., and Amniox Medical Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Number of Accident and Trauma Cases
4.2.2 Increasing Awareness about the Benefits Offered by Amniotic Membrane
4.2.3 Rising Research on Stem Cell Biology and Regenerative Medicine
4.3 Market Restraints
4.3.1 Lack of Standardized Guidelines
4.3.2 Lack of Skilled Professionals
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Enzyme
5.1.1 Cryopreserved Amniotic Membrane
5.1.2 Dehydrated Amniotic Membrane
5.2 By Application
5.2.1 Ophthalmology
5.2.2 Surgical Wounds
5.2.3 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amnio Technology LLC
6.1.2 Celularity Inc.
6.1.3 Human Regenerative Technologies LLC
6.1.4 Katena Products Inc.
6.1.5 MiMedx
6.1.6 Integra LifeSciences Corporation
6.1.7 Skye Biologics Inc.
6.1.8 Amniox Medical Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS